Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm specializing in life sciences, with a focus on healthcare and sustainability. Founded in 1972, the firm has a rich history of backing over 500 companies and managing over €4 billion in assets. Sofinnova Partners is committed to fostering innovation and creating market leaders by investing in breakthrough technologies that address the world's most pressing problems. The firm operates across the entire value chain of life sciences investments, from seed to later-stage, and emphasizes long-term partnerships with entrepreneurs who share their passion for innovation.
Sofinnova Partners
7-11 Boulevard Haussmann, Paris, France 75009
What We Do
Sofinnova Partners is known for being company creators, providing hands-on support to build and manage companies across the European biotech ecosystem.
The firm offers strategic guidance and mentorship to its portfolio companies, leveraging its extensive network and expertise in life sciences.
Sofinnova Partners provides access to its extensive infrastructure and network, supporting the growth and development of its portfolio companies.
The firm offers financial support through its various investment strategies, including seed, early-stage, and later-stage funding.
Portfolio
Creates technology that has the potential to revolutionize life sciences research with its Syntax system, the first bench-top DNA printer powered by Enzymatic DNA Synthesis.
#Biotechnology
Developing the EnfiniT platform, an integrated drug discovery engine.
#Biotechnology
Developed two proprietary Adeno-Associated Viral (AAV) vector platforms to address gene therapy cargo capacity limitations.
#Biotechnology
Offers natural, low-carbon ingredients produced using unique fermentation technology based on a completely circular model.
#Greentech
Focused on developing therapeutics that modulate the immune system to treat chronic inflammatory diseases.
#Biotechnology
Developing groundbreaking treatments to rejuvenate vision in the aging eye.
#Biotechnology
Specializes in innovative treatments for rare genetic diseases through next-generation gene editing technology.
#Biotechnology
Developing innovative infertility treatments, including a minimally invasive procedure called 'ovarian rebalancing'.
#Medtech
Key People
Managing Partner
Chairman & Managing Partner
Managing Partner